作者：
Sung,Choe [1]
;
Hongfang,Wang [1]
;
Courtney D,DiNardo [2]
;
Eytan M,Stein [3]
;
Stéphane,de Botton [4]
;
Gail J,Roboz [5]
;
Jessica K,Altman [6]
;
Alice S,Mims [7]
;
Justin M,Watts [8]
;
Daniel A,Pollyea [9]
;
Amir T,Fathi [10]
;
Martin S,Tallman [3]
;
Hagop M,Kantarjian [2]
;
Richard M,Stone [11]
;
Lynn,Quek [12]
;
Zenon,Konteatis [1]
;
Lenny,Dang [1]
;
Brandon,Nicolay [1]
;
Parham,Nejad [1]
;
Guowen,Liu [1]
;
Vickie,Zhang [1]
;
Hua,Liu [1]
;
Meredith,Goldwasser [1]
;
Wei,Liu [1]
;
Kevin,Marks [1]
;
Chris,Bowden [1]
;
Scott A,Biller [1]
;
Eyal C,Attar [1]
;
Bin,Wu [1]
作者单位：
Agios Pharmaceuticals, Inc., Cambridge, MA.
[1]
University of Texas MD Anderson Cancer Center, Houston, TX.
[2]
Memorial Sloan Kettering Cancer Center, New York, NY.
[3]
Department of Hematology, Institut Gustave Roussy, Villejuif, France.
[4]
Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.
[5]
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.
[6]
The Ohio State University Wexner Medical Center, Columbus, OH.
[7]
Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
[8]
Division of Hematology, University of Colorado School of Medicine, Aurora, CO.
[9]
Massachusetts General Hospital, Harvard Medical School, Boston, MA.
[10]
Dana-Farber Cancer Institute, Boston, MA; and.
[11]
Medical Research Council Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
[12]
DOI
10.1182/bloodadvances.2020001503
PMID
32380538
发布时间
2021-09-25
换一批
换一批
